Approval · Notice of Compliance 5372 · 1994
ZESTORETIC: Notice of Compliance 5372
Issued June 20, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5372
- Date
- June 20, 1994
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Angiotensin converting enzyme inhibitor / diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZESTORETIC | 02103729 | Marketed |
Medicinal ingredients
- LISINOPRIL 10 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB